Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Purpose: To report a case of vitrectomy using intraocular triamcinolone acetonide (TA), in which TA remained in the macular hole after surgery.
Design: Observational case report.
Methods: A 60-year-old Japanese man had a Stage II macular hole in the right eye with best-corrected visual acuity of 20/50. A pars plana vitrectomy using TA was performed. Visual acuity and anatomic results were followed up for a period of 8 weeks.
Results: On the sixth postoperative day, residual TA deposition was observed in the macular hole. On the 14th postoperative day, no residual TA was found and the macular hole was successfully closed. The best-corrected visual acuity of the right eye improved to 20/15.
Conclusions: Residual TA in the macular hole after vitrectomy did not interfere with macular hole repair either anatomically or functionally.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0002-9394(03)00674-3 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!